Cyclo CRLLIF serves as a dual inhibitor of hypoxia-inducible factors HIF1 and HIF2, disrupting the interaction between HIF1-alpha and HIF2-alpha with HIF1-beta. It exhibits dissociation constants (KD) of 14.5 µM for HIF1-alpha and 10.2 µM for HIF2-alpha within the PAS-B domains.
Formula:
C36H59N9O6S
Target:
HIF/HIF Prolyl-Hydroxylase
* VAT and and shipping costs not included. Errors and price changes excepted
